Guía de suplementos para la diabetes y los problemas de azúcar

Must Try

Saludissimo
Saludissimohttps://saludissimo.com
Saludissimo, Salud a tope

Guía de Suplementos para la Diabetes y Problemas Relacionados

La diabetes es una condición que afecta a millones de personas en todo el mundo, y su manejo eficaz es crucial para mantener una buena salud.

Además de la atención médica convencional, muchos individuos recurren a suplementos naturales como complemento para abordar los problemas relacionados con la diabetes.

En esta guía, exploraremos los suplementos clave, sus beneficios y cómo integrarlos de manera segura en tu rutina diaria.

Glucosa en sangre e insulina, dos puntos fundamentales

La gestión efectiva de la diabetes requiere un equilibrio cuidadoso entre el control de la glucosa en sangre y la regulación de la insulina. Además de adherirse a las indicaciones médicas, los suplementos dietéticos pueden desempeñar un papel crucial en este proceso.

Tomar suplementos de vitaminas específicas, especialmente aquellos diseñados para apoyar el control de la diabetes, puede ser beneficioso. Los individuos diabéticos enfrentan un mayor riesgo cardiovascular y renal, lo que subraya la importancia de una ingesta nutricional adecuada.

Algunos suplementos, como ciertas vitaminas y minerales, pueden ayudar a reducir estos riesgos y mejorar la salud general. La vitamina D, por ejemplo, ha demostrado beneficios en la regulación del azúcar en la sangre.

En resumen, la inclusión estratégica de suplementos de vitaminas y minerales puede ser fundamental para optimizar el control de la diabetes y mejorar la salud cardiovascular y renal.

suplementos para la diabetes y los problemas de azúcar

Guía de suplementos para la diabetes y los problemas de azúcar en sangre

En esta Guía de Suplementos para la Diabetes y Problemas de Azúcar en Sangre, es esencial recordar que no sustituye el consejo médico. Antes de incorporar nuevos suplementos nutricionales o medicamentos para la diabetes, siempre consulta con tu profesional de la salud.

Exploraremos cómo controlar la diabetes y prevenir el riesgo de desarrollarla mediante la inclusión estratégica de suplementos de vitamina D y otros suplementos alimenticios.

La atención a la ingesta nutricional y la consideración de los niveles de azúcar son fundamentales para quienes padecen diabetes. Sigue este guía con precaución y en colaboración con tu equipo médico para optimizar tu salud.

Descargo de responsabilidad médica

Antes de explorar los suplementos específicos, es imperativo reconocer que la eficacia de estos puede variar según el individuo.

Además, los suplementos no deben considerarse como sustitutos de una dieta equilibrada y un estilo de vida saludable.

Consulta siempre a tu médico antes de realizar cambios significativos en tu régimen de suplementos.

Guía de suplementos para la diabetes y los problemas de azúcar

Tipos de suplementos

Existen diferentes tipos de suplementos que pueden ayudar a las personas con diabetes a abordar sus necesidades específicas. Estos se dividen en suplementos principales, secundarios y prometedores.

Suplementos principales

Fibra

¿Qué la hace un suplemento principal?

La fibra, clave en el control de la glucosa en sangre, no solo ayuda a ralentizar la absorción de azúcares, sino que también puede ayudar a prevenir el riesgo de desarrollar diabetes.

Su papel fundamental la convierte en un suplemento principal para quienes buscan optimizar el tratamiento y control de la diabetes.

¿Cómo consumirla?

Puedes obtener fibra de fuentes naturales como frutas, verduras y granos enteros.

Los suplementos de fibra también están disponibles y pueden ser beneficiosos para aquellos que luchan por obtener suficiente de su dieta.

suplementos de fibra para la glucosa en la sangre

Suplementos secundarios

Berberina

¿Por qué es un suplemento secundario?

La Berberina, al mejorar la sensibilidad a la insulina y reducir la glucosa en sangre, se posiciona como un suplemento secundario esencial en el tratamiento y la prevención de la diabetes tipo 2.

Su eficacia en personas que padecen diabetes la destaca como una valiosa opción en el cuidado de la salud.

Inositol (para mujeres con SOP)

¿Por qué es un suplemento secundario?

El Inositol, con su efecto beneficioso, se convierte en un suplemento secundario valioso para mujeres con síndrome de ovario poliquístico (SOP), ayudando a controlar la resistencia a la insulina.

Su potencial en el tratamiento y control de la diabetes tipo 2 destaca la importancia de tomar este suplemento para el bienestar hormonal y metabólico.

Magnesio

¿Por qué es un suplemento secundario?

El magnesio, esencial en la regulación de la insulina, emerge como un suplemento secundario clave en el tratamiento y prevención de la diabetes.

Su importancia para aquellos con riesgo de diabetes tipo 2 subraya la necesidad de incorporar este mineral para optimizar la salud metabólica y reducir el riesgo de desarrollar la enfermedad.

suplementos de magnesio para la glucosa en la sangre

Zinc

¿Por qué es un suplemento secundario?

El zinc contribuye a la función normal de la insulina y puede ser importante para quienes tienen niveles bajos de este mineral.

Suplementos prometedores

Cromo

El cromo puede ayudar a mejorar la sensibilidad a la insulina y regular los niveles de glucosa en sangre.

suplementos de cromo para la glucosa en la sangre

Canela

Se ha sugerido que la canela puede tener efectos positivos en la glucosa en sangre y la resistencia a la insulina.

Inositol (para personas con diabetes tipo 2 y prediabetes)

Además de ser beneficioso para mujeres con SOP, el inositol puede ser útil para personas con diabetes tipo 2 y prediabetes.

¿Cómo combinar mis suplementos?

Es esencial abordar esta pregunta de manera personalizada, ya que las necesidades de cada individuo son diferentes. A continuación, se presentan algunos combos generales que podrían ser útiles.

Combos de suplementación

En los Combos de Suplementación, las personas que tienen diabetes tipo 2 deben considerar suplementos de ácido y niveles bajos de vitamina D.

La suplementación con vitamina D puede ser esencial, junto con cambios en el estilo de vida, para reducir el mayor riesgo de desarrollar diabetes.

Combo básico

– Fibra
– Berberina

placeholder

Combos específicos de suplementación

Para personas con niveles elevados de glucosa en sangre en ayunas o HbA1c

– Cromo
– Magnesio

Para personas con resistencia a la insulina

– Inositol
– Zinc

Para personas con diabetes o prediabetes que hacen ejercicio regularmente

– Canela
– Berberina

Para personas con una dieta alta en carbohidratos

– Cromo
– Fibra

Para mujeres con síndrome de ovario poliquístico (SOP)

– Inositol
– Zinc

Mejor no inventar...

Suplementos no aprobados o desaconsejados

Cuando se explora el mundo de los suplementos para la diabetes, es vital evitar aquellos no aprobados o desaconsejados por profesionales de la salud.

La seguridad y eficacia deben ser prioridades fundamentales en la elección de cualquier suplemento.

En resumen, la gestión de la diabetes va más allá de la medicación convencional.

Los suplementos, siendo aliados valiosos, deben integrarse con precaución y siempre bajo la supervisión de un profesional de la salud.

La combinación adecuada de suplementos, junto con una dieta equilibrada y un estilo de vida saludable, puede contribuir significativamente al tratamiento y prevención de la diabetes.

Es esencial considerar productos específicos para la diabetes, teniendo en cuenta el riesgo de desarrollar diabetes tipo 2. Al adoptar esta perspectiva integral, se puede reducir el riesgo y mejorar la gestión de la enfermedad.

Recuerda que cada elección, desde los suplementos a base de hierbas hasta los productos especializados, debe ser guiada por el objetivo común de optimizar la salud y reducir el riesgo de diabetes.

*Saludissimo*

Referencias y estudios

1. Berg JM, Tymoczko JL, Stryer L Food Intake and Starvation Induce Metabolic Changes. Biochemistry. 5th edition.. (2002)
2. Fournier PA, Fairchild TJ, Ferreira LD, Bräu L Post-exercise muscle glycogen repletion in the extreme: effect of food absence
and active recovery. J Sports Sci Med. (2004 Sep 1)
3. Clarke DD & Sokoloff L Substrates of Cerebral Metabolism.
4. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB Brain metabolism during short-term starvation in
humans. J Cereb Blood Flow Metab. (1994 Jan)
5. White H, Venkatesh B Clinical review: ketones and brain injury. Crit Care. (2011 Apr 6)
6. Cahill GF Jr Fuel metabolism in starvation. Annu Rev Nutr. (2006)
7. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr Liver and kidney metabolism during prolonged starvation. J Clin Invest.
(1969 Mar)
8. Maehlum S, Hermansen L Muscle glycogen concentration during recovery after prolonged severe exercise in fasting subjects.
Scand J Clin Lab Invest. (1978 Oct)
9. Wasserman DH Four grams of glucose. Am J Physiol Endocrinol Metab. (2009 Jan)
10. De Meyts P The Insulin Receptor and Its Signal Transduction Network.
11. Mouri MI, Badireddy M Hyperglycemia.
12. Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X New insights into oxidative stress and inflammation
during diabetes mellitus-accelerated atherosclerosis. Redox Biol. (2019 Jan)
13. Lee SC, Chan JC Evidence for DNA damage as a biological link between diabetes and cancer. Chin Med J (Engl). (2015 Jun 5)
14. Hamed SA Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol.
(2017 Apr)
15. Einarson TR, Acs A, Ludwig C, Panton UH Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature
review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. (2018 Jun 8)
16. Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, Cao F An updated meta-analysis of cohort studies: Diabetes and risk of
Alzheimer’s disease. Diabetes Res Clin Pract. (2017 Feb)
17. Yue X, Li H, Yan H, Zhang P, Chang L, Li T Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of
Population-Based Cohort Studies. Medicine (Baltimore). (2016 May)
18. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP Type 2 diabetes and cancer: umbrella review of meta-analyses of
observational studies. BMJ. (2015 Jan 2)
19. Magliano DJ, Islam RM, Barr ELM, Gregg EW, Pavkov ME, Harding JL, Tabesh M, Koye DN, Shaw JE Trends in incidence of
total or type 2 diabetes: systematic review. BMJ. (2019 Sep 11)
20. CDC Diabetes Statistic Report. Centers for Disease Control and Prevention.
21. Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C Macrovascular Complications in Patients with
Diabetes and Prediabetes. Biomed Res Int. (2017)
22. Gummesson A, Nyman E, Knutsson M, Karpefors M Effect of weight reduction on glycated haemoglobin in weight loss trials in
patients with type 2 diabetes. Diabetes Obes Metab. (2017 Sep)
23. Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ Lifestyle weight-loss intervention outcomes in overweight and obese
adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. (2015 Sep)
24. Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ Physical activity and the risk of type 2 diabetes: a systematic review and
dose-response meta-analysis. Eur J Epidemiol. (2015 Jul)
25. Liubaoerjijin Y, Terada T, Fletcher K, Boulé NG Effect of aerobic exercise intensity on glycemic control in type 2 diabetes: a
meta-analysis of head-to-head randomized trials. Acta Diabetol. (2016 Oct)
26. Pan B, Ge L, Xun YQ, Chen YJ, Gao CY, Han X, Zuo LQ, Shan HQ, Yang KH, Ding GW, Tian JH Exercise training modalities in
patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Int J Behav Nutr Phys Act. (2018 Jul 25)
27. American Diabetes Association Diabetes Care.
28. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR Day-to-day variability of fasting plasma glucose in newly
diagnosed type 2 diabetic subjects. Diabetes Care. (1999 Mar)
 
29. DeVries JH, Bailey TS, Bhargava A, Gerety G, Gumprecht J, Heller S, Lane W, Wysham CH, Zinman B, Bak BA, Hachmann-
Nielsen E, Philis-Tsimikas A Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia
 
in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials. Diabetes Obes Metab.
(2019 Mar)
30. Radin MS Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. (2014 Feb)
 
62
 
31. Virtue MA, Furne JK, Nuttall FQ, Levitt MD Relationship between GHb concentration and erythrocyte survival determined from
breath carbon monoxide concentration. Diabetes Care. (2004 Apr)
32. American Diabetes Association Standards of Medical Care in Diabetes-2020 Abridged for Primary Care Providers. Clin
Diabetes. (2020 Jan)
33. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C Activation of oxidative stress by acute glucose fluctuations
compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. (2006 Apr 12)
34. Ceriello A, Ihnat MA ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med.
(2010 Aug)
35. Brownlee M The pathobiology of diabetic complications: a unifying mechanism. Diabetes. (2005 Jun)
36. Monnier L, Colette C Glycemic variability: should we and can we prevent it?. Diabetes Care. (2008 Feb)
37. Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. (2015
Jan-Feb)
38. Carmina E, Stanczyk FZ, Lobo RA Chapter 34 – Laboratory Assessment. Yen & Jaffe’s Reproductive Endocrinology (Seventh
Edition). (2014)
39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC Homeostasis model assessment: insulin resistance
and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. (1985 Jul)
40. Salgado AL, Carvalho Ld, Oliveira AC, Santos VN, Vieira JG, Parise ER Insulin resistance index (HOMA-IR) in the differentiation
of patients with non-alcoholic fatty liver disease and healthy individuals. Arq Gastroenterol. (2010 Apr-Jun)
41. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ Quantitative insulin sensitivity check index: a simple,
accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. (2000 Jul)
42. Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E Defining insulin resistance from hyperinsulinemic-euglycemic
clamps. Diabetes Care. (2012 Jul)
43. Kim JK Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods Mol Biol. (2009)
44. Archer E, Lavie CJ, Hill JO The Failure to Measure Dietary Intake Engendered a Fictional Discourse on Diet-Disease Relations.
Front Nutr. (2018 Nov 13)
45. Archer E, Pavela G, Lavie CJ The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity
Research and the Scientific Formulation of National Dietary Guidelines. Mayo Clin Proc. (2015 Jul)
46. Miller TM, Abdel-Maksoud MF, Crane LA, Marcus AC, Byers TE Effects of social approval bias on self-reported fruit and
vegetable consumption: a randomized controlled trial. Nutr J. (2008 Jun 27)
47. Dwyer JT, Krall EA, Coleman KA The problem of memory in nutritional epidemiology research. J Am Diet Assoc. (1987 Nov)
48. Weickert MO, Pfeiffer AF Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. (2008 Mar)
49. Prasad KN, Bondy SC Dietary Fibers and Their Fermented Short-Chain Fatty Acids in Prevention of Human Diseases. Mech
Ageing Dev. (2018 Oct 15)
50. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L, Xu C, Ren Z, Xu Y, Xu S, Shen H, Zhu X, Shi Y,
Shen Q, Dong W, Liu R, Ling Y, Zeng Y, Wang X, Zhang Q, Wang J, Wang L, Wu Y, Zeng B, Wei H, Zhang M, Peng Y, Zhang C
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. (2018 Mar 9)
51. McNabney SM, Henagan TM Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer,
Obesity and Insulin Resistance. Nutrients. (2017 Dec 12)
52. Dreher ML Introduction to Dietary Fiber. Dietary Fiber in Health and Disease. (2018)
53. McRorie JW Jr Evidence-Based Approach to Fiber Supplements and Clinically Meaningful Health Benefits, Part 1: What to Look
for and How to Recommend an Effective Fiber Therapy. Nutr Today. (2015 Mar)
54. Jovanovski E, Khayyat R, Zurbau A, Komishon A, Mazhar N, Sievenpiper JL, Blanco Mejia S, Ho HVT, Li D, Jenkins AL, Duvnjak
L, Vuksan V Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and
Meta-analysis of Randomized Controlled Trials. Diabetes Care. (2019 May)
55. McRae MP Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses. J Chiropr Med. (2018
Mar)
56. Thompson SV, Hannon BA, An R, Holscher HD Effects of isolated soluble fiber supplementation on body weight, glycemia, and
insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Am J
Clin Nutr. (2017 Dec)
57. Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D’Alessio DA Psyllium fiber improves glycemic control proportional to loss of
glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being
treated for type 2 diabetes mellitus. Am J Clin Nutr. (2015 Dec)
58. Dikeman CL, Fahey GC Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr. (2006)
59. Institute of Medicine et al. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein,
and Amino Acids. The National Academies Press. (2005)
60. McGill CR, Fulgoni VL 3rd, Devareddy L Ten-year trends in fiber and whole grain intakes and food sources for the United
63
 
States population: National Health and Nutrition Examination Survey 2001-2010. Nutrients. (2015 Feb 9)
61. Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L,
Uelmen S, Urbanski PB, Yancy WS Jr Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes
Care. (2019 May)
62. Dreher ML Fiber in Type 2 Diabetes Prevention and Management. Dietary Fiber in Health and Disease. (2017 NOV)
63. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L Carbohydrate quality and human health: a series of
systematic reviews and meta-analyses. Lancet. (2019 Feb 2)
64. Dahl WJ, Stewart ML Position of the Academy of Nutrition and Dietetics: Health Implications of Dietary Fiber. J Acad Nutr Diet.
(2015 Nov)
 
65. Kohmoto T, Tsuji K, Kaneko T, Shiota M, Fukui F, Takaku H, Nakagawa Y, Ichikawa T, Kobayash S Metabolism of (13)C-
Isomaltooligosaccharides in Healthy Men. Biosci Biotechnol Biochem. (1992 Jan)
 
66. Oku T, Nakamura S Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-
sucrose, and isomalto-oligosaccharide in healthy human subjects. Eur J Clin Nutr. (2003 Sep)
 
67. Gourineni V, Stewart ML, Icoz D, Zimmer JP Gastrointestinal Tolerance and Glycemic Response of Isomaltooligosaccharides in
Healthy Adults. Nutrients. (2018 Mar 3)
 
68. Gardner CD, Trepanowski JF, Del Gobbo LC, Hauser ME, Rigdon J, Ioannidis JPA, Desai M, King AC Effect of Low-Fat vs Low-
Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin
 
Secretion: The DIETFITS Randomized Clinical Trial. JAMA. (2018 Feb 20)
69. Slavin JL Dietary fiber and body weight. Nutrition. (2005 Mar)
70. Anderson JW, Konz EC, Jenkins DJ Health advantages and disadvantages of weight-reducing diets: a computer analysis and
critical review. J Am Coll Nutr. (2000 Oct)
71. Fernandez N, Lopez C, Díez R, Garcia JJ, Diez MJ, Sahagun A, Sierra M Drug interactions with the dietary fiber Plantago ovata
husk. Expert Opin Drug Metab Toxicol. (2012 Nov)
72. Fong SY, Gao Q, Zuo Z Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review. Evid
Based Complement Alternat Med. (2013)
73. McRorie JW Jr Evidence-Based Approach to Fiber Supplements and Clinically Meaningful Health Benefits, Part 2: What to Look
for and How to Recommend an Effective Fiber Therapy. Nutr Today. (2015 Mar)
74. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KG Dietary fibres, fibre
analogues, and glucose tolerance: importance of viscosity. Br Med J. (1978 May 27)
75. Wang H, Zhu C, Ying Y, Luo L, Huang D, Luo Z Metformin and berberine, two versatile drugs in treatment of common metabolic
diseases. Oncotarget. (2017 Sep 11)
76. Liang Y, Xu X, Yin M, Zhang Y, Huang L, Chen R, Ni J Effects of berberine on blood glucose in patients with type 2 diabetes
mellitus: a systematic literature review and a meta-analysis. Endocr J. (2019 Jan 28)
77. Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y A clinical study on the short-term effect of
berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J
Endocrinol. (2012 Jan)
78. Yan HM, Xia MF, Wang Y, Chang XX, Yao XZ, Rao SX, Zeng MS, Tu YF, Feng R, Jia WP, Liu J, Deng W, Jiang JD, Gao X
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One. (2015 Aug 7)
79. Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Espinel-Bermúdez MC Effect of berberine
administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. (2013 Oct)
80. Asemani S, Montazeri V, Baradaran B, Tabatabiefar MA, Pirouzpanah S The Effects of Berberis Vulgaris Juice on Insulin Indices
in Women with Benign Breast Disease: A Randomized Controlled Clinical Trial. Iran J Pharm Res. (2018 Winter)
81. Lazavi F, Mirmiran P, Sohrab G, Nikpayam O, Angoorani P, Hedayati M The barberry juice effects on metabolic factors and
oxidative stress in patients with type 2 diabetes: A randomized clinical trial. Complement Ther Clin Pract. (2018 May)
82. Moazezi Z, Qujeq D Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes. Jundishapur J Nat
Pharm Prod. (2014 Apr 7)
83. Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, Hajhassani G The Effects of Berberis vulgaris Fruit Extract on Serum
Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients. Iran J
Pharm Res. (2012 Spring)
84. Dong H, Wang N, Zhao L, Lu F Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.
Evid Based Complement Alternat Med. (2012)
85. Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G Meta-analysis of the effect and safety of berberine in the treatment of
type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. (2015 Feb 23)
86. Li MF, Zhou XM, Li XL The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A
Meta-Analysis and Systematic Review. Evid Based Complement Alternat Med. (2018 Nov 14)
87. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH Repeated administration of berberine inhibits cytochromes P450 in humans. Eur
J Clin Pharmacol. (2012 Feb)
 
64
 
88. Chan E Displacement of bilirubin from albumin by berberine. Biol Neonate. (1993)
89. Imanshahidi M, Hosseinzadeh H Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent,
berberine. Phytother Res. (2008 Aug)
90. Croze ML, Soulage CO Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. (2013 Oct)
 
91. Croze ML, Géloën A, Soulage CO Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-
fat diet: benefits of a dietary myo-inositol supplementation. Br J Nutr. (2015 Jun 28)
 
92. Zeng L, Yang K Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine.
(2018 Jan)
93. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J Myo-inositol effects in women with PCOS: a meta-analysis of randomized
controlled trials. Endocr Connect. (2017 Nov)
94. Shokrpour M, Foroozanfard F, Afshar Ebrahimi F, Vahedpoor Z, Aghadavod E, Ghaderi A, Asemi Z Comparison of myo-inositol
and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with
polycystic ovary syndrome: a randomized controlled clinical trial. Gynecol Endocrinol. (2019 May)
95. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G Ovulatory and metabolic effects of D-chiro-inositol in the polycystic
ovary syndrome. N Engl J Med. (1999 Apr 29)
96. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE Effects of d-chiro-inositol in lean women with
the polycystic ovary syndrome. Endocr Pract. (2002 Nov-Dec)
97. M Nordio, E Proietti The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS
overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. (2012 May)
 
98. Miñambres I, Cuixart G, Gonçalves A, Corcoy R Effects of inositol on glucose homeostasis: Systematic review and meta-
analysis of randomized controlled trials. Clin Nutr. (2019 Jun)
 
99. D’Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A myo-Inositol
supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a
prospective, randomized, placebo-controlled study. Diabetes Care. (2013 Apr)
100. Matarrelli B, Vitacolonna E, D’Angelo M, Pavone G, Mattei PA, Liberati M, Celentano C Effect of dietary myo-inositol
supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized
controlled trial. J Matern Fetal Neonatal Med. (2013 Jul)
101. Farren M, Daly N, McKeating A, Kinsley B, Turner MJ, Daly S The Prevention of Gestational Diabetes Mellitus With Antenatal
Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care. (2017 Jun)
102. Bo S, Pisu E Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol.
(2008 Feb)
103. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?. Diabetes. (2016
Jan)
 
104. Mazidi M, Rezaie P, Banach M Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-
analysis. Arch Med Sci. (2018 Jun)
 
105. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol.
(2007 Mar)
106. Rosanoff A, Weaver CM, Rude RK Suboptimal magnesium status in the United States: are the health consequences
underestimated?. Nutr Rev. (2012 Mar)
107. Verma H, Garg R Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic
review and meta-analysis. J Hum Nutr Diet. (2017 Oct)
108. Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F A systematic review and meta-analysis of
randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol
Res. (2016 Sep)
109. Veronese N, Watutantrige-Fernando S, Luchini C, Solmi M, Sartore G, Sergi G, Manzato E, Barbagallo M, Maggi S, Stubbs B
Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and
meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. (2016 Dec)
110. Institute of Medicine Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. The National
Academies Press. (1997)
111. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Dietary Reference
Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.
112. Pazianas M, Abrahamsen B, Ferrari S, Russell RG Eliminating the need for fasting with oral administration of bisphosphonates.
Ther Clin Risk Manag. (2013)
113. Crippa G, Sverzellati E, Giorgi-Pierfranceschi M, Carrara GC Magnesium and cardiovascular drugs: interactions and therapeutic
role. Ann Ital Med Int. (1999 Jan-Mar)
114. Sarafidis PA, Georgianos PI, Lasaridis AN Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating
diuretic therapy. Expert Opin Drug Saf. (2010 Mar)
 
65
 
115. Center for Drug Evaluation. Low Magnesium Levels Can Be Associated with Long-Term Use of Proton Pump Inhibitor Drugs
(PPIs).. Drug Safety and Availability – FDA Drug Safety Communication..
116. Witkowski M, Hubert J, Mazur A Methods of assessment of magnesium status in humans: a systematic review. Magnes Res.
(2011 Dec)
117. Yoshimura Y, Fujisaki K, Yamamoto T, Shinohara Y Pharmacokinetic Studies of Orally Administered Magnesium Oxide in Rats.
Yakugaku Zasshi. (2017 May 1)
118. Firoz M, Graber M Bioavailability of US commercial magnesium preparations. Magnes Res. (2001 Dec)
119. Walker AF, Marakis G, Christie S, Byng M Mg citrate found more bioavailable than other Mg preparations in a randomised,
double-blind study. Magnes Res. (2003 Sep)
120. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY Magnesium bioavailability from magnesium citrate and magnesium oxide. J
Am Coll Nutr. (1990 Feb)
121. Ranade VV, Somberg JC Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to
humans. Am J Ther. (2001 Sep-Oct)
122. Wessells KR, Singh GM, Brown KH Estimating the global prevalence of inadequate zinc intake from national food balance
sheets: effects of methodological assumptions. PLoS One. (2012)
123. Kumssa DB, Joy EJ, Ander EL, Watts MJ, Young SD, Walker S, Broadley MR Dietary calcium and zinc deficiency risks are
decreasing but remain prevalent. Sci Rep. (2015 Jun 22)
124. Fernández-Cao JC, Warthon-Medina M, Hall Moran V, Arija V, Doepking C, Lowe NM Dietary zinc intake and whole blood zinc
 
concentration in subjects with type 2 diabetes versus healthy subjects: A systematic review, meta-analysis and meta-
regression. J Trace Elem Med Biol. (2018 Sep)
 
125. Fukunaka A, Fujitani Y Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity. Int J Mol Sci. (2018 Feb 6)
126. Ranasinghe P, Pigera S, Galappatthy P, Katulanda P, Constantine GR Zinc and diabetes mellitus: understanding molecular
mechanisms and clinical implications. Daru. (2015 Sep 17)
127. Norouzi S, Adulcikas J, Sohal SS, Myers S Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes
and metabolic disease. J Biomed Sci. (2017 Nov 20)
128. Pérez A, Rojas P, Carrasco F, Basfi-Fer K, Pérez-Bravo F, Codoceo J, Inostroza J, Ruz M Zinc Supplementation Does Not
Affect Glucagon Response to Intravenous Glucose and Insulin Infusion in Patients with Well-Controlled Type 2 Diabetes. Biol
Trace Elem Res. (2018 Oct)
129. Partida-Hernández G, Arreola F, Fenton B, Cabeza M, Román-Ramos R, Revilla-Monsalve MC Effect of zinc replacement on
lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother. (2006 May)
130. Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, Looi WF, Long LH, Halliwell B Oral zinc supplementation does not
improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis. (2011
Nov)
131. Al-Maroof RA, Al-Sharbatti SS Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of
type 2 diabetics. Saudi Med J. (2006 Mar)
132. Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S Effects of zinc and multimineral vitamin supplementation on
glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. (2011 Jan 26)
133. Khan MI, Siddique KU, Ashfaq F, Ali W, Reddy HD, Mishra A Effect of high-dose zinc supplementation with oral hypoglycemic
agents on glycemic control and inflammation in type-2 diabetic nephropathy patients. J Nat Sci Biol Med. (2013 Jul)
134. Islam MR, Attia J, Ali L, McEvoy M, Selim S, Sibbritt D, Akhter A, Akter S, Peel R, Faruque O, Mona T, Lona H, Milton AH Zinc
supplementation for improving glucose handling in pre-diabetes: A double blind randomized placebo controlled pilot study.
Diabetes Res Clin Pract. (2016 May)
135. Ranasinghe P, Wathurapatha WS, Galappatthy P, Katulanda P, Jayawardena R, Constantine GR Zinc supplementation in
prediabetes: A randomized double-blind placebo-controlled clinical trial. J Diabetes. (2018 May)
136. Momen-Heravi M, Barahimi E, Razzaghi R, Bahmani F, Gilasi HR, Asemi Z The effects of zinc supplementation on wound healing
and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Wound Repair
Regen. (2017 May)
137. Parham M, Amini M, Aminorroaya A, Heidarian E Effect of zinc supplementation on microalbuminuria in patients with type 2
diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. (2008 Summer)
138. Afkhami-Ardekani M, Karimi M, Mohammadi SM, Nourani F Effect of Zinc Sulfate Supplementation on Lipid and Glucose in Type
2 Diabetic Patients. Pakistan Journal of Nutrition. (2008)
139. El Dib R, Gameiro OL, Ogata MS, Módolo NS, Braz LG, Jorge EC, do Nascimento P Jr, Beletate V Zinc supplementation for the
prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database Syst Rev. (2015 May 28)
140. Roshanravan N, Alizadeh M, Hedayati M, Asghari-Jafarabadi M, Mesri Alamdari N, Anari F, Tarighat-Esfanjani A Effect of zinc
supplementation on insulin resistance, energy and macronutrients intakes in pregnant women with impaired glucose tolerance.
Iran J Public Health. (2015 Feb)
141. Lobene AJ, Kindler JM, Jenkins NT, Pollock NK, Laing EM, Grider A, Lewis RD Zinc Supplementation Does Not Alter Indicators
of Insulin Secretion and Sensitivity in Black and White Female Adolescents. J Nutr. (2017 Jul)
 
66
 
142. Cruz KJ, Morais JB, de Oliveira AR, Severo JS, Marreiro DD The Effect of Zinc Supplementation on Insulin Resistance in Obese
Subjects: a Systematic Review. Biol Trace Elem Res. (2017 Apr)
143. Chiba M, Katayama K, Takeda R, Morita R, Iwahashi K, Onishi Y, Kita H, Nishio A, Kanno T, Saito T, Maeda K, Naito M, Michida
T, Ito T Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine. Hepatol Res.
(2013 Apr)
144. Duncan A, Yacoubian C, Watson N, Morrison I The risk of copper deficiency in patients prescribed zinc supplements. J Clin
Pathol. (2015 Sep)
145. Willis MS, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, Bhushan V, Kroft SH Zinc-induced copper
deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. (2005 Jan)
146. Institute of Medicine et al. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron,
Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. The National Academies Press. (2001)
147. Maret W, Sandstead HH Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. (2006)
148. Maverakis E, Fung MA, Lynch PJ, Draznin M, Michael DJ, Ruben B, Fazel N Acrodermatitis enteropathica and an overview of
zinc metabolism. J Am Acad Dermatol. (2007 Jan)
149. Neldner KH, Hambidge KM Zinc therapy of acrodermatitis enteropathica. N Engl J Med. (1975 Apr 24)
150. Wegmüller R, Tay F, Zeder C, Brnic M, Hurrell RF Zinc absorption by young adults from supplemental zinc citrate is comparable
with that from zinc gluconate and higher than from zinc oxide. J Nutr. (2014 Feb)
151. Barrie SA, Wright JV, Pizzorno JE, Kutter E, Barron PC Comparative absorption of zinc picolinate, zinc citrate and zinc
gluconate in humans. Agents Actions. (1987 Jun)
152. Gandia P, Bour D, Maurette JM, Donazzolo Y, Duchène P, Béjot M, Houin G A bioavailability study comparing two oral
formulations containing zinc (Zn bis-glycinate vs. Zn gluconate) after a single administration to twelve healthy female
volunteers. Int J Vitam Nutr Res. (2007 Jul)
153. Bel-Serrat S, Stammers AL, Warthon-Medina M, Moran VH, Iglesia-Altaba I, Hermoso M, Moreno LA, Lowe NM, EURRECA
Network Factors that affect zinc bioavailability and losses in adult and elderly populations. Nutr Rev. (2014 May)
154. Schlemmer U, Frølich W, Prieto RM, Grases F Phytate in foods and significance for humans: food sources, intake, processing,
bioavailability, protective role and analysis. Mol Nutr Food Res. (2009 Sep)
155. Hua Y, Clark S, Ren J, Sreejayan N Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. (2012
Apr)
156. Vincent JB Is the Pharmacological Mode of Action of Chromium(III) as a Second Messenger?. Biol Trace Elem Res. (2015 Jul)
157. Kaur B, Henry J Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res. (2014)
158. Ngala RA, Awe MA, Nsiah P The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in
type 2 diabetes mellitus. A case – control study. PLoS One. (2018 Jul 5)
159. Flores CR, Puga MP, Wrobel K, Garay Sevilla ME, Wrobel K Trace elements status in diabetes mellitus type 2: possible role of
the interaction between molybdenum and copper in the progress of typical complications. Diabetes Res Clin Pract. (2011 Mar)
160. Gluschenko N, Vasylyshyn Kh, Roschupkin A, Lekishvili S, Gladchenko O THE CONTENT OF MICROELEMENTS IN BLOOD
SERUM AND ERYTHROCYTES IN CHILDREN WITH DIABETES MELLITUS TYPE I DEPENDING ON LEVEL OF GLYCEMIC
CONTROL. Georgian Med News. (2016 Jan)
161. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA Copper, chromium, manganese, iron, nickel, and zinc
levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. (2008 Apr)
162. Chen S, Jin X, Shan Z, Li S, Yin J, Sun T, Luo C, Yang W, Yao P, Yu K, Zhang Y, Cheng Q, Cheng J, Bao W, Liu L Inverse
Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study. Nutrients. (2017 Mar 17)
163. Zhou Q, Guo W, Jia Y, Xu J Comparison of Chromium and Iron Distribution in Serum and Urine among Healthy People and
Prediabetes and Diabetes Patients. Biomed Res Int. (2019 Feb 24)
164. Huang H, Chen G, Dong Y, Zhu Y, Chen H Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus:
Results from a pooled analysis. Mol Nutr Food Res. (2018 Jan)
165. Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, Caldito G, Hoeldtke R, Levine SN, Bass PF 3rd Effect of
chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in
type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res. (2012 Aug)
166. Guimarães MM, Martins Silva Carvalho AC, Silva MS Chromium nicotinate has no effect on insulin sensitivity, glycemic control,
and lipid profile in subjects with type 2 diabetes. J Am Coll Nutr. (2013)
167. Abraham AS, Brooks BA, Eylath U The effects of chromium supplementation on serum glucose and lipids in patients with and
without non-insulin-dependent diabetes. Metabolism. (1992 Jul)
168. Fazelian S, Rouhani MH, Bank SS, Amani R Chromium supplementation and polycystic ovary syndrome: A systematic review
and meta-analysis. J Trace Elem Med Biol. (2017 Jul)
169. Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S, Rezaeinejad M, Razavi M, Sepidarkish M The Effects of
Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic
Review and Meta-Analysis of Randomized Clinical Trials. Horm Metab Res. (2018 Mar)
 
67
 
170. Tang XL, Sun Z, Gong L Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-
analysis. J Obstet Gynaecol Res. (2018 Jan)
 
171. McIver DJ, Grizales AM, Brownstein JS, Goldfine AB Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-
Containing Supplements. J Nutr. (2015 Dec)
 
172. Frauchiger MT, Wenk C, Colombani PC Effects of acute chromium supplementation on postprandial metabolism in healthy
young men. J Am Coll Nutr. (2004 Aug)
173. Riales R, Albrink MJ Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density
lipoprotein of adult men. Am J Clin Nutr. (1981 Dec)
174. Amato P, Morales AJ, Yen SS Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body
composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci. (2000 May)
175. Masharani U, Gjerde C, McCoy S, Maddux BA, Hessler D, Goldfine ID, Youngren JF Chromium supplementation in non-obese
non-diabetic subjects is associated with a decline in insulin sensitivity. BMC Endocr Disord. (2012 Nov 30)
176. Thomas VL, Gropper SS Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol
Trace Elem Res. (1996 Dec)
177. Wilson BE, Gondy A Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese
young subjects. Diabetes Res Clin Pract. (1995 Jun)
178. Offenbacher EG, Rinko CJ, Pi-Sunyer FX The effects of inorganic chromium and brewer’s yeast on glucose tolerance, plasma
lipids, and plasma chromium in elderly subjects. Am J Clin Nutr. (1985 Sep)
179. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD Chromium picolinate toxicity. Ann Pharmacother. (1998 Apr)
180. Medagama AB The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J. (2015
Oct 16)
181. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA Cinnamon improves glucose and lipids of people with type 2
diabetes. Diabetes Care. (2003 Dec)
182. Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ Cinnamon supplementation does not improve
glycemic control in postmenopausal type 2 diabetes patients. J Nutr. (2006 Apr)
183. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, Hahn A Effects of a cinnamon extract on plasma
glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. (2006 May)
184. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA Effects of a water-soluble cinnamon extract on body
composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. (2006 Dec 28)
185. Suppapitiporn S, Kanpaksi N, Suppapitiporn S The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc
Thai. (2006 Sep)
186. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA Antioxidant effects of a cinnamon extract in people with
impaired fasting glucose that are overweight or obese. J Am Coll Nutr. (2009 Feb)
187. Crawford P Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled
trial. J Am Board Fam Med. (2009 Sep-Oct)
188. Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, Amiri F Effects of cinnamon consumption on glycemic
status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med. (2012 Aug)
189. Lu T, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin
level in Chinese patients with type 2 diabetes. Nutr Res. (2012 Jun)
190. Hasanzade F, Toliat M, Emami SA, Emamimoghaadam Z The Effect of Cinnamon on Glucose of Type II Diabetes Patients. J
Tradit Complement Med. (2013 Jul)
191. Wickenberg J, Lindstedt S, Nilsson J, Hlebowicz J Cassia cinnamon does not change the insulin sensitivity or the liver enzymes
in subjects with impaired glucose tolerance. Nutr J. (2014 Sep 24)
192. Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F Effects of Cinnamon Consumption on Glycemic
Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients. (2017 Sep 8)
 
193. Akilen R, Tsiami A, Devendra D, Robinson N Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-
ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med. (2010 Oct)
 
194. Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M Controlling type 2 diabetes mellitus
with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. (2016 Sep)
195. Gupta Jain S, Puri S, Misra A, Gulati S, Mani K Effect of oral cinnamon intervention on metabolic profile and body composition of
Asian Indians with metabolic syndrome: a randomized double -blind control trial. Lipids Health Dis. (2017 Jun 12)
196. Zare R, Nadjarzadeh A, Zarshenas MM, Shams M, Heydari M Efficacy of cinnamon in patients with type II diabetes mellitus:
A randomized controlled clinical trial. Clin Nutr. (2019 Apr)
 
197. Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH, Aston CE Effect of cinnamon on glucose and lipid levels in non insulin-
dependent type 2 diabetes. Diabetes Care. (2007 Sep)
 
198. Khan R, Khan Z, Shah SH Cinnamon May Reduce Glucose, Lipid and Cholesterol Level in Type 2 Diabetic Individuals. Pakistan
Journal of Nutrition. (2010)
 
68
 
199. Askari F, Rashidkhani B, Hekmatdoost A Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin
resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res. (2014 Feb)
200. Hajimonfarednejad M, Nimrouzi M, Heydari M, Zarshenas MM, Raee MJ, Jahromi BN Insulin resistance improvement by
cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial. Phytother Res.
(2018 Feb)
201. Borzoei A, Rafraf M, Asghari-Jafarabadi M Cinnamon improves metabolic factors without detectable effects on adiponectin in
women with polycystic ovary syndrome. Asia Pac J Clin Nutr. (2018)
202. Solomon TP, Blannin AK Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab. (2007
Nov)
203. Hlebowicz J, Darwiche G, Björgell O, Almér LO Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety
in healthy subjects. Am J Clin Nutr. (2007 Jun)
204. Hlebowicz J, Hlebowicz A, Lindstedt S, Björgell O, Höglund P, Holst JJ, Darwiche G, Almér LO Effects of 1 and 3 g cinnamon on
gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like
peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr. (2009 Mar)
205. Mettler S, Schwarz I, Colombani PC Additive postprandial blood glucose-attenuating and satiety-enhancing effect of cinnamon
and acetic acid. Nutr Res. (2009 Oct)
206. Beejmohun V, Peytavy-Izard M, Mignon C, Muscente-Paque D, Deplanque X, Ripoll C, Chapal N Acute effect of Ceylon
cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover
clinical trial in healthy volunteers. BMC Complement Altern Med. (2014 Sep 23)
207. Markey O, McClean CM, Medlow P, Davison GW, Trinick TR, Duly E, Shafat A Effect of cinnamon on gastric emptying, arterial
stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast. Cardiovasc Diabetol. (2011 Sep 7)
208. Magistrelli A, Chezem JC Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese
adults. J Acad Nutr Diet. (2012 Nov)
209. Bernardo MA, Silva ML, Santos E, Moncada MM, Brito J, Proença L, Singh J, de Mesquita MF Effect of Cinnamon Tea on
Postprandial Glucose Concentration. J Diabetes Res. (2015)
210. Gutierrez JL, Bowden RG, Willoughby DS Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does
Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women. J Diet Suppl. (2016)
211. Hochkogler CM, Hoi JK, Lieder B, Müller N, Hans J, Widder S, Ley JP, Somoza V Cinnamyl Isobutyrate Decreases Plasma
Glucose Levels and Total Energy Intake from a Standardized Breakfast: A Randomized, Crossover Intervention. Mol Nutr Food
Res. (2018 Sep)
212. Sproll C, Ruge W, Andlauer C, Godelmann R, Lachenmeier DW HPLC analysis and safety assessment of coumarin in foods.
Food Chem. (2008 Jul 15)
213. Abraham K, Wöhrlin F, Lindtner O, Heinemeyer G, Lampen A Toxicology and risk assessment of coumarin: focus on human
data. Mol Nutr Food Res. (2010 Feb)
214. Aguilar F, et. al. Coumarin in flavorings and other food ingredients with flavoring properties ‐ Scientific Opinion of the Panel on
Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). EFSA Journal. (2008 OCT)
215. Hajimonfarednejad M, Ostovar M, Raee MJ, Hashempur MH, Mayer JG, Heydari M Cinnamon: A systematic review of adverse
events. Clin Nutr. (2019 Apr)
216. Ranasinghe P, Jayawardena R, Pigera S, Wathurapatha WS, Weeratunga HD, Premakumara GAS, Katulanda P, Constantine GR,
Galappaththy P Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in
healthy adults: a phase I clinical trial. BMC Complement Altern Med. (2017 Dec 28)
217. Abraham K, Pfister M, Wöhrlin F, Lampen A Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods
compared to isolated coumarin: a four-way crossover study in human volunteers. Mol Nutr Food Res. (2011 Apr)
218. Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ Effects of pinitol isolated from soybeans on glycaemic control and
cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr.
(2005 Mar)
219. Kim HJ, Park KS, Lee SK, Min KW, Han KA, Kim YK, Ku BJ Effects of pinitol on glycemic control, insulin resistance and
adipocytokine levels in patients with type 2 diabetes mellitus. Ann Nutr Metab. (2012)
220. Davis A, Christiansen M, Horowitz JF, Klein S, Hellerstein MK, Ostlund RE Jr Effect of pinitol treatment on insulin action in
subjects with insulin resistance. Diabetes Care. (2000 Jul)
221. Choi JY, Shin SK, Jeon SM, Baek NI, Chung HG, Jeong TS, Lee KT, Lee MK, Choi MS Dose-response study of sajabalssuk
ethanol extract from Artemisia princeps Pampanini on blood glucose in subjects with impaired fasting glucose or mild type 2
diabetes. J Med Food. (2011 Jan-Feb)
 
222. Santamaria A, Giordano D, Corrado F, Pintaudi B, Interdonato ML, Vieste GD, Benedetto AD, D’Anna R One-year effects of myo-
inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric. (2012 Oct)
 
223. Giordano D, Corrado F, Santamaria A, Quattrone S, Pintaudi B, Di Benedetto A, D’Anna R Effects of myo-inositol
supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study.
Menopause. (2011 Jan)
 
69
 
224. Cho YY, Baek NI, Chung HG, Jeong TS, Lee KT, Jeon SM, Kim HJ, McGregor RA, Choi MS Randomized controlled trial of
Sajabalssuk (Artemisia princeps Pampanini) to treat pre-diabetes. Eur. J. Integr. Med.. (2012 SEP)
 
225. Mijares AH, Banuls C, Llopis SR, Álvarez A, Orden S, Puchol OR, Víctor VM, Rocha M Chronic consumption of an inositol-
enriched beverage ameliorates endothelial dysfunction and oxidative stress in type 2 diabetes. J. Funct. Foods. (2015 OCT)
 
226. Bañuls C, Rovira-Llopis S, Falcón R, Veses S, Monzó N, Víctor VM, Rocha M, Hernández-Mijares A Chronic consumption of an
inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized
controlled trial. Clin Nutr. (2016 Jun)
227. Miura T, Takagi S, Ishida T Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosa L.) and
Corosolic Acid. Evid Based Complement Alternat Med. (2012)
228. Stohs SJ, Miller H, Kaats GR A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid.
Phytother Res. (2012 Mar)
229. Takagi S, Miura T, Ishibashi C, Kawata T, Ishihara E, Gu Y, Ishida T Effect of corosolic acid on the hydrolysis of disaccharides. J
Nutr Sci Vitaminol (Tokyo). (2008 Jun)
230. Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita
Y, Yamada Y, Seino Y Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Res Clin Pract. (2006 Aug)
231. Judy WV, Hari SP, Stogsdill WW, Judy JS, Naguib YM, Passwater R Antidiabetic activity of a standardized extract (Glucosol)
from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study. J Ethnopharmacol. (2003 Jul)
232. Manaf A, Tjandrawinata RR, Malinda D Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive
fraction of Cinnamomum burmanii and Lagerstroemia speciosa. Drug Des Devel Ther. (2016 Mar 29)
233. Tjokroprawiro A, Murtiwi S, Tjandrawinata RR DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and
Lagerstroemia speciosa, in type-2 diabetes mellitus patients inadequately controlled by metformin and other oral antidiabetic
agents. J Complement Integr Med. (2016 Dec 1)
234. Canale RE, Farney TM, McCarthy CG, Bloomer RJ A blend of phellodendron and crape myrtle improves glucose tolerance in
exercise-trained men. Nutr Metab Insights. (2011 Sep 13)
235. Layman DK, Walker DA Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. (2006 Jan)
236. Chartrand D, Da Silva MS, Julien P, Rudkowska I Influence of Amino Acids in Dairy Products on Glucose Homeostasis: The
Clinical Evidence. Can J Diabetes. (2017 Jun)
237. Blomstrand E, Andersson S, Hassmén P, Ekblom B, Newsholme EA Effect of branched-chain amino acid and carbohydrate
supplementation on the exercise-induced change in plasma and muscle concentration of amino acids in human subjects. Acta
Physiol Scand. (1995 Feb)
238. Gualano AB, Bozza T, Lopes De Campos P, Roschel H, Dos Santos Costa A, Luiz Marquezi M, Benatti F, Herbert Lancha Junior
A Branched-chain amino acids supplementation enhances exercise capacity and lipid oxidation during endurance exercise
after muscle glycogen depletion. J Sports Med Phys Fitness. (2011 Mar)
239. Wiśnik P, Chmura J, Ziemba AW, Mikulski T, Nazar K The effect of branched chain amino acids on psychomotor performance
during treadmill exercise of changing intensity simulating a soccer game. Appl Physiol Nutr Metab. (2011 Dec)
240. Smith JW, Krings BM, Shepherd BD, Waldman HS, Basham SA, McAllister MJ Effects of carbohydrate and branched-chain
amino acid beverage ingestion during acute upper body resistance exercise on performance and postexercise hormone
response. Appl Physiol Nutr Metab. (2018 May)
241. Ullrich SS, Fitzgerald PC, Schober G, Steinert RE, Horowitz M, Feinle-Bisset C Intragastric administration of leucine or isoleucine
lowers the blood glucose response to a mixed-nutrient drink by different mechanisms in healthy, lean volunteers. Am J Clin
Nutr. (2016 Nov)
242. Nuttall FQ, Schweim K, Gannon MC Effect of orally administered isoleucine with and without glucose on insulin, glucagon and
glucose concentrations in non-diabetic subjects. ESPEN. (2008 AUG)
243. Kalogeropoulou D, Lafave L, Schweim K, Gannon MC, Nuttall FQ Leucine, when ingested with glucose, synergistically
stimulates insulin secretion and lowers blood glucose. Metabolism. (2008 Dec)
244. Casperson SL, Sheffield-Moore M, Hewlings SJ, Paddon-Jones D Leucine supplementation chronically improves muscle protein
synthesis in older adults consuming the RDA for protein. Clin Nutr. (2012 Aug)
245. Leenders M, Verdijk LB, van der Hoeven L, van Kranenburg J, Hartgens F, Wodzig WK, Saris WH, van Loon LJ Prolonged
leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. J Nutr. (2011
Jun)
246. Verhoeven S, Vanschoonbeek K, Verdijk LB, Koopman R, Wodzig WK, Dendale P, van Loon LJ Long-term leucine
supplementation does not increase muscle mass or strength in healthy elderly men. Am J Clin Nutr. (2009 May)
247. Gannon NP, Schnuck JK, Vaughan RA BCAA Metabolism and Insulin Sensitivity – Dysregulated by Metabolic Status?. Mol Nutr
Food Res. (2018 Mar)
248. Brunetta HS, de Camargo CQ, Nunes EA Does L-leucine supplementation cause any effect on glucose homeostasis in rodent
models of glucose intolerance? A systematic review. Amino Acids. (2018 Dec)
249. Kurpad AV, Regan MM, Raj T, Gnanou JV Branched-chain amino acid requirements in healthy adult human subjects. J Nutr.
(2006 Jan)
 
70
 
250. Pinto CL, Botelho PB, Pimentel GD, Campos-Ferraz PL, Mota JF Creatine supplementation and glycemic control: a systematic
review. Amino Acids. (2016 Sep)
251. Forbes SC, Sletten N, Durrer C, Myette-Côté É, Candow D, Little JP Creatine Monohydrate Supplementation Does Not
Augment Fitness, Performance, or Body Composition Adaptations in Response to Four Weeks of High-Intensity Interval Training
in Young Females. Int J Sport Nutr Exerc Metab. (2017 Jun)
252. Gualano B, DE Salles Painneli V, Roschel H, Artioli GG, Neves M Jr, De Sá Pinto AL, Da Silva ME, Cunha MR, Otaduy MC, Leite
Cda C, Ferreira JC, Pereira RM, Brum PC, Bonfá E, Lancha AH Jr Creatine in type 2 diabetes: a randomized, double-blind,
placebo-controlled trial. Med Sci Sports Exerc. (2011 May)
253. Gualano B, Novaes RB, Artioli GG, Freire TO, Coelho DF, Scagliusi FB, Rogeri PS, Roschel H, Ugrinowitsch C, Lancha AH Jr
Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic
training. Amino Acids. (2008 Feb)
254. van Loon LJ, Murphy R, Oosterlaar AM, Cameron-Smith D, Hargreaves M, Wagenmakers AJ, Snow R Creatine supplementation
increases glycogen storage but not GLUT-4 expression in human skeletal muscle. Clin Sci (Lond). (2004 Jan)
255. Newman JE, Hargreaves M, Garnham A, Snow RJ Effect of creatine ingestion on glucose tolerance and insulin sensitivity in
men. Med Sci Sports Exerc. (2003 Jan)
256. Rooney KB, Bryson JM, Digney AL, Rae CD, Thompson CH Creatine supplementation affects glucose homeostasis but not
insulin secretion in humans. Ann Nutr Metab. (2003)
257. Manjarrez-Montes de Oca R, Farfán-González F, Camarillo-Romero S, Tlatempa-Sotelo P, Francisco-Argüelles C, Kormanowski
 
A, González-Gallego J, Alvear-Ordenes I Effects of creatine supplementation in taekwondo practitioners. Nutr Hosp. (2013 Mar-
Apr)
 
258. Derave W, Eijnde BO, Verbessem P, Ramaekers M, Van Leemputte M, Richter EA, Hespel P Combined creatine and protein
supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans. J
Appl Physiol (1985). (2003 May)
259. Earnest CP, Almada AL, Mitchell TL High-performance capillary electrophoresis-pure creatine monohydrate reduces blood
lipids in men and women. Clin Sci (Lond). (1996 Jul)
260. Alves CR, Ferreira JC, de Siqueira-Filho MA, Carvalho CR, Lancha AH Jr, Gualano B Creatine-induced glucose uptake in type 2
diabetes: a role for AMPK-α?. Amino Acids. (2012 Oct)
261. Op ‘t Eijnde B, Ursø B, Richter EA, Greenhaff PL, Hespel P Effect of oral creatine supplementation on human muscle GLUT4
protein content after immobilization. Diabetes. (2001 Jan)
262. Yan-Do R, MacDonald PE Impaired «Glycine»-mia in Type 2 Diabetes and Potential Mechanisms Contributing to Glucose
Homeostasis. Endocrinology. (2017 May 1)
263. Cruz M, Maldonado-Bernal C, Mondragón-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, Kumate J Glycine
treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J Endocrinol
Invest. (2008 Aug)
264. Gannon MC, Nuttall JA, Nuttall FQ The metabolic response to ingested glycine. Am J Clin Nutr. (2002 Dec)
 
265. Zhang H, Lv Y, Li Z, Sun L, Guo W The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-
analysis of randomized controlled trials. J Matern Fetal Neonatal Med. (2019 Jul)
 
266. Guo X, Guo S, Miao Z, Li Z, Zhang H Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A
systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. J Diabetes Complications.
(2018 Mar)
267. Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J Treatments for women with gestational diabetes mellitus:
an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. (2018 Aug 14)
268. Stohs SJ, Ray S Anti-diabetic and Anti-hyperlipidemic Effects and Safety of Salacia reticulata and Related Species. Phytother
Res. (2015 Jul)
269. Kushwaha PS, Singh AK, Keshari AK, Maity S, Saha S An Updated Review on the Phytochemistry, Pharmacology, and Clinical
Trials of Salacia oblonga. Pharmacogn Rev. (2016 Jul-Dec)
270. Heacock PM, Hertzler SR, Williams JA, Wolf BW Effects of a medical food containing an herbal alpha-glucosidase inhibitor on
postprandial glycemia and insulinemia in healthy adults. J Am Diet Assoc. (2005 Jan)
271. Collene AL, Hertzler SR, Williams JA, Wolf BW Effects of a nutritional supplement containing Salacia oblonga extract and
insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults. Nutrition.
(2005 Jul-Aug)
272. Williams JA, Choe YS, Noss MJ, Baumgartner CJ, Mustad VA Extract of Salacia oblonga lowers acute glycemia in patients with
type 2 diabetes. Am J Clin Nutr. (2007 Jul)
273. Koteshwar P, Raveendra KR, Allan JJ, Goudar KS, Venkateshwarlu K, Agarwal A Effect of NR-Salacia on post-prandial
hyperglycemia: A randomized double blind, placebo-controlled, crossover study in healthy volunteers. Pharmacogn Mag. (2013
Oct)
274. Jeykodi S, Deshpande J, Juturu V Salacia Extract Improves Postprandial Glucose and Insulin Response: A Randomized
Double-Blind, Placebo Controlled, Crossover Study in Healthy Volunteers. J Diabetes Res. (2016)
 
71
 
275. Hao L, Schlussel Y, Fieselmann K, Schneider SH, Shapses SA Appetite and Gut Hormones Response to a Putative α-
Glucosidase Inhibitor, Salacia Chinensis, in Overweight/Obese Adults: A Double Blind Randomized Controlled Trial. Nutrients.
 
(2017 Aug 12)
276. Shivaprasad HN, Bhanumathy M, Sushma G, Midhun T, Raveendra KR, Sushma KR, Venkateshwarlu K Salacia reticulata
 
improves serum lipid profiles and glycemic control in patients with prediabetes and mild to moderate hyperlipidemia: a double-
blind, placebo-controlled, randomized trial. J Med Food. (2013 Jun)
 
277. Zhu W, Du Y, Meng H, Dong Y, Li L A review of traditional pharmacological uses, phytochemistry, and pharmacological
activities of Tribulus terrestris. Chem Cent J. (2017 Jul 11)
278. Samani NB, Jokar A, Soveid M, Heydari M, Mosavat SH Efficacy of the Hydroalcoholic Extract of Tribulus terrestris on the
Serum Glucose and Lipid Profile of Women With Diabetes Mellitus: A Double-Blind Randomized Placebo-Controlled Clinical Trial.
J Evid Based Complementary Altern Med. (2016 Oct)
279. Lim J, Henry CJ, Haldar S Vinegar as a functional ingredient to improve postprandial glycemic control-human intervention
findings and molecular mechanisms. Mol Nutr Food Res. (2016 Aug)
280. Shishehbor F, Mansoori A, Shirani F Vinegar consumption can attenuate postprandial glucose and insulin responses; a
systematic review and meta-analysis of clinical trials. Diabetes Res Clin Pract. (2017 May)
281. Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T Vinegar intake reduces body weight, body fat mass, and serum triglyceride
levels in obese Japanese subjects. Biosci Biotechnol Biochem. (2009 Aug)
282. Derakhshandeh-Rishehri SM, Heidari-Beni M, Feizi A, Askari GR, Entezari MH Effect of honey vinegar syrup on blood sugar and
lipid profile in healthy subjects. Int J Prev Med. (2014 Dec)
283. Johnston CS, White AM, Kent SM Preliminary evidence that regular vinegar ingestion favorably influences hemoglobin A1c
values in individuals with type 2 diabetes mellitus. Diabetes Res Clin Pract. (2009 May)
 
284. Panetta CJ, Jonk YC, Shapiro AC Prospective randomized clinical trial evaluating the impact of vinegar on lipids in non-
diabetics. WJCD. (2013)
 
285. Gheflati A, Bashiri R, Ghadiri-Anari A, Reza JZ, Kord MT, Nadjarzadeh A The effect of apple vinegar consumption on glycemic
indices, blood pressure, oxidative stress, and homocysteine in patients with type 2 diabetes and dyslipidemia: A randomized
controlled clinical trial. Clin Nutr ESPEN. (2019 Oct)
286. Jasbi P, Baker O, Shi X, Gonzalez LA, Wang S, Anderson S, Xi B, Gu H, Johnston CS Daily red wine vinegar ingestion for eight
weeks improves glucose homeostasis and affects the metabolome but does not reduce adiposity in adults. Food Funct. (2019
Nov 1)
287. Sargeant LA, Wareham NJ, Bingham S, Day NE, Luben RN, Oakes S, Welch A, Khaw KT Vitamin C and hyperglycemia in the
European Prospective Investigation into Cancer–Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care.
(2000 Jun)
288. Kositsawat J, Freeman VL Vitamin C and A1c relationship in the National Health and Nutrition Examination Survey (NHANES)
2003-2006. J Am Coll Nutr. (2011 Dec)
289. Will JC, Byers T Does diabetes mellitus increase the requirement for vitamin C?. Nutr Rev. (1996 Jul)
290. Wilson R, Willis J, Gearry R, Skidmore P, Fleming E, Frampton C, Carr A Inadequate Vitamin C Status in Prediabetes and Type 2
Diabetes Mellitus: Associations with Glycaemic Control, Obesity, and Smoking. Nutrients. (2017 Sep 9)
291. Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO 3rd, Wang Y, Katz A, Levine M, Quon MJ High-dose oral vitamin C
partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial
dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol. (2006 Jan)
292. Tousoulis D, Antoniades C, Vasiliadou C, Kourtellaris P, Koniari K, Marinou K, Charakida M, Ntarladimas I, Siasos G, Stefanadis C
Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the
inflammatory process in patients with type 2 diabetes mellitus. Heart. (2007 Feb)
293. Dakhale GN, Chaudhari HV, Shrivastava M Supplementation of vitamin C reduces blood glucose and improves glycosylated
hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. (2011)
294. Mahmoudabadi MM, Djalali M, Djazayery SA, Keshavarz SA, Eshraghian MR, Yaraghi AA, Askari G, Ghiasvand R, Zarei M Effects
of eicosapentaenoic acid and vitamin C on glycemic indices, blood pressure, and serum lipids in type 2 diabetic Iranian males. J
Res Med Sci. (2011 Mar)
295. Gutierrez AD, Duran-Valdez E, Robinson I, de Serna DG, Schade DS Does short-term vitamin C reduce cardiovascular risk in
type 2 diabetes?. Endocr Pract. (2013 Sep-Oct)
296. Siavash M, Amini M Vitamin C may have similar beneficial effects to Gemfibrozil on serum high-density lipoprotein-cholesterol in
type 2 diabetic patients. J Res Pharm Pract. (2014 Jul)
297. Ellulu MS, Rahmat A, Patimah I, Khaza’ai H, Abed Y Effect of vitamin C on inflammation and metabolic markers in hypertensive
and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther. (2015 Jul 1)
298. Mason SA, Della Gatta PA, Snow RJ, Russell AP, Wadley GD Ascorbic acid supplementation improves skeletal muscle oxidative
stress and insulin sensitivity in people with type 2 diabetes: Findings of a randomized controlled study. Free Radic Biol Med.
(2016 Apr)
299. Bishop N, Schorah CJ, Wales JK The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind,
crossover study. Diabet Med. (1985 Mar)
 
72
 
300. Mason SA, Rasmussen B, van Loon LJC, Salmon J, Wadley GD Ascorbic acid supplementation improves postprandial
glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial. Diabetes
Obes Metab. (2019 Mar)
301. Bhatt J, Thomas S, Nanjan M Effect of oral supplementation of vitamin C on glycemic control and lipid profile in patients with
type 2 diabetes mellitus. Int J Pharm Pharm Sci. (2012)
302. Ghaffari P, Nadiri M, Gharib A, Rahimi F The effects of vitamin C on diabetic patients. Der Pharmacia Lettre. (2015)
303. Ashor AW, Werner AD, Lara J, Willis ND, Mathers JC, Siervo M Effects of vitamin C supplementation on glycaemic control: a
systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. (2017 Dec)
304. Choo VL, Viguiliouk E, Blanco Mejia S, Cozma AI, Khan TA, Ha V, Wolever TMS, Leiter LA, Vuksan V, Kendall CWC, de Souza RJ,
 
Jenkins DJA, Sievenpiper JL Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-
analysis of controlled intervention studies. BMJ. (2018 Nov 21)
 
305. Evans RA, Frese M, Romero J, Cunningham JH, Mills KE Chronic fructose substitution for glucose or sucrose in food or
beverages has little effect on fasting blood glucose, insulin, or triglycerides: a systematic review and meta-analysis. Am J Clin
Nutr. (2017 Aug)
306. Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, Mirrahimi A, Yu ME, Carleton AJ, Di Buono M, Jenkins AL,
Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ Effect of fructose on glycemic control in diabetes: a systematic
review and meta-analysis of controlled feeding trials. Diabetes Care. (2012 Jul)
307. Noronha JC, Braunstein CR, Blanco Mejia S, Khan TA, Kendall CWC, Wolever TMS, Leiter LA, Sievenpiper JL The Effect of Small
Doses of Fructose and Its Epimers on Glycemic Control: A Systematic Review and Meta-Analysis of Controlled Feeding Trials.
Nutrients. (2018 Nov 20)
308. Tian Y, Su L, Wang J, Duan X, Jiang X Fruit and vegetable consumption and risk of the metabolic syndrome: a meta-analysis.
Public Health Nutr. (2018 Mar)
 
309. Wu Y, Zhang D, Jiang X, Jiang W Fruit and vegetable consumption and risk of type 2 diabetes mellitus: a dose-response meta-
analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. (2015 Feb)
 
310. Tappy L Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders. J Exp Biol. (2018 Mar 7)
311. Ter Horst KW, Schene MR, Holman R, Romijn JA, Serlie MJ Effect of fructose consumption on insulin sensitivity in nondiabetic
subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr. (2016 Dec)
312. Rojas E, Bermúdez V, Motlaghzadeh Y, Mathew J, Fidilio E, Faria J, Rojas J, de Bravo MC, Contreras J, Mantilla LP, Angarita L,
Sepúlveda PA, Kuzmar I Stevia rebaudiana Bertoni and Its Effects in Human Disease: Emphasizing Its Role in Inflammation,
Atherosclerosis and Metabolic Syndrome. Curr Nutr Rep. (2018 Jul 11)
313. Momtazi-Borojeni AA, Esmaeili SA, Abdollahi E, Sahebkar A A Review on the Pharmacology and Toxicology of Steviol
Glycosides Extracted from Stevia rebaudiana. Curr Pharm Des. (2017)
314. Carakostas MC, Curry LL, Boileau AC, Brusick DJ Overview: the history, technical function and safety of rebaudioside A, a
naturally occurring steviol glycoside, for use in food and beverages. Food Chem Toxicol. (2008 Jul)
315. Magnuson BA, Carakostas MC, Moore NH, Poulos SP, Renwick AG Biological fate of low-calorie sweeteners. Nutr Rev. (2016
Nov)
316. Ferri LA, Alves-Do-Prado W, Yamada SS, Gazola S, Batista MR, Bazotte RB Investigation of the antihypertensive effect of oral
crude stevioside in patients with mild essential hypertension. Phytother Res. (2006 Sep)
317. Hsieh MH, Chan P, Sue YM, Liu JC, Liang TH, Huang TY, Tomlinson B, Chow MS, Kao PF, Chen YJ Efficacy and tolerability of
oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin Ther. (2003
Nov)
318. Chan P, Tomlinson B, Chen YJ, Liu JC, Hsieh MH, Cheng JT A double-blind placebo-controlled study of the effectiveness and
tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol. (2000 Sep)
319. Rizwan F, Rashid HU, Yesmine S, Monjur F, Chatterjee TK Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in
patients with chronic kidney disease (stage I to stage III). Contemp Clin Trials Commun. (2018 Aug 21)
320. Mayasari NR, Susetyowati, Wahyuningsih MSH, Probosuseno Antidiabetic Effect of Rosella-Stevia Tea on Prediabetic Women
in Yogyakarta, Indonesia. J Am Coll Nutr. (2018 Jul)
321. Ritu M, Nandini J Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect
on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. (2016 Sep)
322. Barriocanal LA, Palacios M, Benitez G, Benitez S, Jimenez JT, Jimenez N, Rojas V Apparent lack of pharmacological effect of
steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive
individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol. (2008 Jun)
323. Maki KC, Curry LL, Reeves MS, Toth PD, McKenney JM, Farmer MV, Schwartz SL, Lubin BC, Boileau AC, Dicklin MR,
Carakostas MC, Tarka SM Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes
mellitus. Food Chem Toxicol. (2008 Jul)
324. Abstracts of the 42nd EASD (European Association for the Study of Diabetes) Annual Meeting, Copenhagen, Denmark, 14 – 17
September 2006.. Diabetologia. (2006-Sep)
325. Onakpoya IJ, Heneghan CJ Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic
73
 
review and meta-analysis of randomised clinical trials. Eur J Prev Cardiol. (2015 Dec)
326. Wei-Te Huang, Ching-Yeh Tu, Fen-Yu Wang, Sheng-Teng Huang Literature review of liver injury induced by Tinospora crispa
associated with two cases of acute fulminant hepatitis. Complement Ther Med. (2019 Feb)
327. Sriyapai C,Dhumma-upakorn R, Sangwatanaroj S, Kongkathip N, Krittiyanunt S Hypoglycemic Effect of Tinospora crispa Dry
Powder in Outpatients with Metabolic Syndrome at King Chulalongkorn Memorial Hospital. Journal of Health Research. (2009
SEPT)
328. Sangsuwan C, Udompanthurak S, Vannasaeng S, Thamlikitkul V Randomized controlled trial of Tinospora crispa for additional
therapy in patients with type 2 diabetes mellitus. J Med Assoc Thai. (2004 May)
329. Thomas A, Rajesh EK, Kumar DS The Significance of Tinospora crispa in Treatment of Diabetes Mellitus. Phytother Res. (2016
Mar)
330. Klangjareonchai T, Roongpisuthipong C The effect of Tinospora crispa on serum glucose and insulin levels in patients with type
2 diabetes mellitus. J Biomed Biotechnol. (2012)
331. Langrand J, Regnault H, Cachet X, Bouzidi C, Villa AF, Serfaty L, Garnier R, Michel S Toxic hepatitis induced by a herbal
medicine: Tinospora crispa. Phytomedicine. (2014 Jul-Aug)
332. Ahmad W, Jantan I, Bukhari SN Tinospora crispa (L.) Hook. f. & Thomson: A Review of Its Ethnobotanical, Phytochemical, and
Pharmacological Aspects. Front Pharmacol. (2016 Mar 21)
333. Dhingra D, Michael M, Rajput H, Patil RT Dietary fibre in foods: a review. J Food Sci Technol. (2012 Jun)
334. Marlett JA Content and composition of dietary fiber in 117 frequently consumed foods. J Am Diet Assoc. (1992 Feb)
335. Schwingshackl L, Hoffmann G, Lampousi AM, Knüppel S, Iqbal K, Schwedhelm C, Bechthold A, Schlesinger S, Boeing H Food
groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol.
(2017 May)
336. Schwingshackl L, Hoffmann G, Iqbal K, Schwedhelm C, Boeing H Food groups and intermediate disease markers: a systematic
review and network meta-analysis of randomized trials. Am J Clin Nutr. (2018 Sep 1)
337. Haripriya S, Premakumari S Effect of wheat bran on diabetic subjects. INDJSRT.
338. Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D, Vidgen E, Parker T, Lau H, Connelly PW, Teitel J,
Singer W, Vandenbroucke AC, Leiter LA, Josse RG Effect of wheat bran on glycemic control and risk factors for cardiovascular
disease in type 2 diabetes. Diabetes Care. (2002 Sep)
339. Tripkovic L, Muirhead NC, Hart KH, Frost GS, Lodge JK The effects of a diet rich in inulin or wheat fibre on markers of
cardiovascular disease in overweight male subjects. J Hum Nutr Diet. (2015 Oct)
340. Lu ZX, Walker KZ, Muir JG, O’Dea K Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin
Nutr. (2004 Apr)
341. Garcia AL, Steiniger J, Reich SC, Weickert MO, Harsch I, Machowetz A, Mohlig M, Spranger J, Rudovich NN, Meuser F, Doerfer
J, Katz N, Speth M, Zunft HJ, Pfeiffer AH, Koebnick C Arabinoxylan fibre consumption improved glucose metabolism, but did
not affect serum adipokines in subjects with impaired glucose tolerance. Horm Metab Res. (2006 Nov)
342. van der Merwe J, Brooks NE, Myburgh KH Three weeks of creatine monohydrate supplementation affects dihydrotestosterone
to testosterone ratio in college-aged rugby players. Clin J Sport Med. (2009 Sep)
343. Hamada K, Randall VA Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a
key to male pattern baldness. Br J Dermatol. (2006 Apr)
344. Trüeb RM Molecular mechanisms of androgenetic alopecia. Exp Gerontol. (2002 Aug-Sep)
345. Vatani DS, Faraji J, Soori R, Mogharnasi M The effects of creatine supplementation on performance and hormonal response in
amateur swimmers. SCI SPORT. (2011 NOV)
346. Arazi H, Rahmaninia F, Hosseini K, Asadi A Effects of short term creatine supplementation and resistance exercises on resting
hormonal and cardiovascular responses. SCI SPORT. (2015 APR)
347. Cook CJ, Crewther BT, Kilduff LP, Drawer S, Gaviglio CM Skill execution and sleep deprivation: effects of acute caffeine or
creatine supplementation – a randomized placebo-controlled trial. J Int Soc Sports Nutr. (2011 Feb 16)
348. Cooke MB, Brabham B, Buford TW, Shelmadine BD, McPheeters M, Hudson GM, Stathis C, Greenwood M, Kreider R, Willoughby
DS Creatine supplementation post-exercise does not enhance training-induced adaptations in middle to older aged males. Eur
J Appl Physiol. (2014 Jun)
349. Crowe MJ, O’Connor DM, Lukins JE The effects of beta-hydroxy-beta-methylbutyrate (HMB) and HMB/creatine
supplementation on indices of health in highly trained athletes. Int J Sport Nutr Exerc Metab. (2003 Jun)
350. Hoffman J, Ratamess N, Kang J, Mangine G, Faigenbaum A, Stout J Effect of creatine and beta-alanine supplementation on
performance and endocrine responses in strength/power athletes. Int J Sport Nutr Exerc Metab. (2006 Aug)
351. Eijnde BO, Hespel P Short-term creatine supplementation does not alter the hormonal response to resistance training. Med Sci
Sports Exerc. (2001 Mar)
352. Volek JS, Ratamess NA, Rubin MR, Gómez AL, French DN, McGuigan MM, Scheett TP, Sharman MJ, Häkkinen K, Kraemer WJ
The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance
training overreaching. Eur J Appl Physiol. (2004 May)
 
74
 
353. Faraji H, Arazi H, Vatani D, Hakimi M The effects of creatine supplementation on sprint running performance and selected
hormonal responses. S AFR J RES SPORT PH. (2010)
354. Rahimi R, Faraji H, Vatani DS, Qaderi M Creatine supplementation alters the body's hormonal response to exercise.
Kinesiology. (2010 JAN)
355. Volek JS, Boetes M, Bush JA, Putukian M, Sebastianelli WJ, Jraemer WJ Response of Testosterone and Cortisol Concentrations
to High-Intensity Resistance Exercise Following Creatine Supplementation. J STRENGTH COND RES. (1997)
356. Wilson JM, Lowery RP, Joy JM, Walters JA, Baier SM, Fuller JC, Stout JR, Norton LE, Sikorski EM, Wilson SM, Duncan NM,
Zanchi NE, Rathmacher J β-Hydroxy-β-methylbutyrate free acid reduces markers of exercise-induced muscle damage and
improves recovery in resistance-trained men. Br J Nutr. (2013 Jan 3)
357. Hoffman JR, Cooper J, Wendell M, Im J, Kang J Effects of beta-hydroxy beta-methylbutyrate on power performance and
indices of muscle damage and stress during high-intensity training. J Strength Cond Res. (2004 Nov)
358. Portal S, Zadik Z, Rabinowitz J, Pilz-Burstein R, Adler-Portal D, Meckel Y, Cooper DM, Eliakim A, Nemet D The effect of HMB
supplementation on body composition, fitness, hormonal and inflammatory mediators in elite adolescent volleyball players: a
prospective randomized, double-blind, placebo-controlled study. Eur J Appl Physiol. (2011 Sep)
359. Slater GJ, Logan PA, Boston T, Gore CJ, Stenhouse A, Hahn AG Beta-hydroxy beta-methylbutyrate (HMB) supplementation
does not influence the urinary testosterone: epitestosterone ratio in healthy males. J Sci Med Sport. (2000 Mar)
- Advertisement -spot_img

DEJA UNA RESPUESTA

Por favor ingrese su comentario!
Por favor ingrese su nombre aquí

spot_img

Latest Recipes

- Advertisement -spot_img

More Recipes Like This

- Advertisement -spot_img